Abstract 10118: PCSK9 Inhibition Augments the Therapeutic Effect of Ezetimibe in Lowering Intestinal Apolipoprotein B Lipoprotein Production

Shirya Rashid,Harry R. Davis,Xi Ai,David Neff,Sergio Fazio

Abstract 10118: PCSK9 Inhibition Augments the Therapeutic Effect of Ezetimibe in Lowering Intestinal Apolipoprotein B Lipoprotein Production

2013

Shirya Rashid
Harry R. Davis
Xi Ai
David Neff
Sergio Fazio

Ezetimibe is an effective therapy to lower circulating low-density lipoprotein (LDL) cholesterol, a maneuver expected to reduce coronary heart disease (CHD) risk. However, ezetimibe concomitantly r...

Keywords:

Apolipoprotein B
PCSK9
Diabetes mellitus
Lipoprotein
Therapeutic effect
Ezetimibe
Medicine
Cardiology
Cell physiology
Internal medicine
Pharmacology
Cholesterol

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations